Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics

(2014) Jean-Francois Timsit et al.   INTENSIVE CARE MEDICINE

Augmented Renal Clearance in the ICU

(2013) Andrew A. Udy et al.   CRITICAL CARE MEDICINE

Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues

(2013) Massimo Antonelli et al.   INTENSIVE CARE MEDICINE

Clinical implications of antibiotic pharmacokinetic principles in the critically ill

(2013) Andrew A. Udy et al.   INTENSIVE CARE MEDICINE

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

(2013) Jan J. De Waele et al.   INTENSIVE CARE MEDICINE

Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients

(2013) M. Carlier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dose modulation: A new concept of antibiotic therapy in the critically ill patient?

(2013) Joao Goncalves-Pereira et al.   JOURNAL OF CRITICAL CARE

Augmented Renal Clearance in the Critically Ill: How to Assess Kidney Function

(2012) Veerle Grootaert et al.   ANNALS OF PHARMACOTHERAPY

Case-Control Study of Drug Monitoring of  -Lactams in Obese Critically Ill Patients

(2012) M. Hites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic

(2012) Jason A Roberts et al.   BMC INFECTIOUS DISEASES

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

(2012) J. M. Dulhunty et al.   CLINICAL INFECTIOUS DISEASES

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia

(2012) A. E. Muller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetics of Beta-Lactam Antibiotics in Patients with Intra-Abdominal Disease: A Structured Review

(2012) Syamhanin Adnan et al.   Surgical Infections

Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials

(2011) Pranita D Tamma et al.   BMC INFECTIOUS DISEASES

Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients

(2011) Andrew A. Udy et al.   CHEST

ARC - Augmented Renal Clearance

(2011) Andrew A. Udy et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Augmented Creatinine Clearance in Traumatic Brain Injury

(2010) Andrew Udy et al.   ANESTHESIA AND ANALGESIA

Therapeutic Drug Monitoring of Piperacillin-Tazobactam Using Spent Dialysate Effluent in Patients Receiving Continuous Venovenous Hemodialysis

(2010) Michael J. Connor et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Optimization of meropenem dosage in the critically ill population based on renal function

(2010) Jared L. Crandon et al.   INTENSIVE CARE MEDICINE

Daily serum piperacillin monitoring is advisable in critically ill patients

(2010) Nicolas Blondiaux et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept

(2010) Jason A. Roberts et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics

(2010) M. Ulldemolins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients

(2009) Katherine M. Shea et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS